SBRI competition guidance: antimicrobial resistance (AMR) in humans

Organisations can apply to develop innovations that address the challenges of antimicrobial resistance (AMR) in humans.



This is a Small Business Research Initiative (SBRI) competition. It is open to organisations of any type and size, from any sector. 100% funding is available to successful applicants.

Please read the full competition scope before you make your application.

Published 9 July 2018